![Kevin Punie: Carmen Criscit provides excellent guidance in decision making between Olaparib and Abemaciclib](https://oncodaily.com/pub/uploads/2024/05/1715888525682_bd4c2f860ef84c98bf09181d31ae674b.jpeg)
Photo from Kevin Punie/X
May 19, 2024, 10:25
Kevin Punie: Carmen Criscit provides excellent guidance in decision making between Olaparib and Abemaciclib
Kevin Punie, Medical Oncologist at GZA Hospitals Sint-Augustinus, Wilrijk, Antwerp, Belgium shared a post on X:
“Carmen Criscit provides excellent guidance in decision making between olaparib and abemaciclib in patients with early-stage high-risk HR+/HER2- breast cancer with overlapping indications.”
Source: Kevin Punie/X